Release date: 1 August 2014
Promoter – Financial Intermediary
GRUPO FERRER INTERNACIONAL SALocation
Description
The project concerns financing of research and development (R&D) activities in a number of well-defined therapeutic areas.
Objectives
The project covers the promoter’s research activities in the fields of central nervous system affections, infections and inflammatory diseases, oncology, diagnostics, and development in cardiovascular, respiratory and other therapeutical areas.
Sector(s)
Proposed EIB finance (Approximate amount)
EUR 50 million
Total cost (Approximate amount)
EUR 116 million
Environmental aspects
The project mainly concerns investments in R&D that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an Environmental Impact Assessment (EIA) under the Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Procurement
The promoter is a private company not operating in the Utilities sector and not having the status of a contracting authority. Thus it is not covered by EU Directives on procurement. However, the promoter’s procurement procedures are expected to be in line with EIB guidelines for private sector projects. The Bank’s services will verify details during the projects' due diligence.
Status
Signed - 7/05/2015
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).